Semaglutide / Tirzepatide Treatment

Semaglutide or tirzepatide are once a week injections for the treatment of diabetes. Wegovy is the brand name version of semaglutide that is FDA approved for chronic weight management.

 

The injections are once a week, subcutaneous injections that can be injected into various subcutaneous sites such as the abdomen or the tricep area. The syringes are the same ones used for insulin injections which are preferred because of the volume injected as well as the needle size which is extremely small compared to other injections.